GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nectar Lifesciences Ltd (BOM:532649) » Definitions » Beginning Cash Position

Nectar Lifesciences (BOM:532649) Beginning Cash Position : ₹0 Mil (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Nectar Lifesciences Beginning Cash Position?

Nectar Lifesciences's Beginning Cash Position for the quarter that ended in Mar. 2024 was ₹0 Mil.

Nectar Lifesciences's annual Beginning Cash Position declined from Mar. 2022 (₹255 Mil) to Mar. 2023 (₹178 Mil) and declined from Mar. 2023 (₹178 Mil) to Mar. 2024 (₹176 Mil).


Nectar Lifesciences Beginning Cash Position Historical Data

The historical data trend for Nectar Lifesciences's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nectar Lifesciences Beginning Cash Position Chart

Nectar Lifesciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 213.28 212.94 255.39 178.08 175.80

Nectar Lifesciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nectar Lifesciences Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Nectar Lifesciences Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Nectar Lifesciences's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Nectar Lifesciences (BOM:532649) Business Description

Traded in Other Exchanges
Address
SCO 38-39, Sector 9d, B-1011/1012, 10th Floor NAURANG HOUSE, Chandigarh, IND, 160009
Nectar Lifesciences Ltd is an India-based pharmaceutical company. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products, The company's product includes cefixime trihydrate, cefdinir, cefprozil, cefoxitin sodium, cefpirome sulphate, and others. Geographically, it derives a majority of its revenue from India.

Nectar Lifesciences (BOM:532649) Headlines

No Headlines